Given the protective effects of Tregs in post-stroke outcomes in other studies (Zhang et al., 2021), we performed immunostaining for Foxp3, a specific nuclear marker for Tregs (Figure 3D and Supplementary Figure 1B). This evidence concerns the gene FOXP3 and stroke disorder.